Understanding Medicare Part D Coverage for Austedo: 6 Key Considerations Austedo (deutetrabenazine) is a prescription medication approved to treat tardive....
Understanding Medicare Part D Coverage for Austedo: 6 Key Considerations
Austedo (deutetrabenazine) is a prescription medication approved to treat tardive dyskinesia and chorea associated with Huntington's disease. For individuals relying on Medicare for their healthcare needs, understanding how Austedo is covered under Medicare Part D can be complex. Medicare Part D plans are offered by private insurance companies approved by Medicare, and coverage details can vary significantly between plans. This guide outlines six key considerations to help you navigate Medicare Part D coverage for Austedo.
1. Austedo's Presence on Your Plan's Formulary
The first crucial step in determining coverage is to check if Austedo is included in your specific Medicare Part D plan's formulary. A formulary is a list of prescription drugs covered by a plan. Formularies can change annually, so it's essential to review the most current list provided by your insurance company. Austedo, being a specialty medication, may not be on every plan's formulary, or it might be listed with specific conditions.
If Austedo is not on your plan's formulary, you may have options such as requesting a formulary exception, or considering a different Part D plan during the Annual Enrollment Period if your medical needs require consistent use of Austedo.
2. Understanding Drug Tiers and Cost-Sharing
Most Medicare Part D plans categorize drugs into different "tiers," with each tier having a distinct cost-sharing level (e.g., copayment or coinsurance). Specialty drugs like Austedo are typically placed on the highest tiers, which usually involve higher out-of-pocket costs for the beneficiary. These tiers often require a percentage coinsurance rather than a flat copayment.
It's important to understand your plan's tier structure and what your expected cost-sharing will be for Austedo. This cost-sharing applies after any annual deductible is met, and can significantly impact your total expenses throughout the year.
3. Navigating Prior Authorization and Step Therapy
Due to Austedo's high cost and specific indications, many Medicare Part D plans require additional steps before coverage is approved. These often include:
Prior Authorization:
Your doctor must submit a request to your plan demonstrating that Austedo is medically necessary for your condition according to the plan's criteria. This often involves providing documentation of diagnosis and previous treatments.
Step Therapy:
Some plans may require you to first try one or more less expensive, alternative medications for your condition. If those alternatives are ineffective or cause unacceptable side effects, the plan may then approve coverage for Austedo.
Understanding and fulfilling these requirements is vital for securing coverage and avoiding delays in receiving your medication.
4. The Impact of the Coverage Gap (Donut Hole)
Medicare Part D includes a "coverage gap" phase, sometimes referred to as the "donut hole." After you and your plan have spent a certain amount on covered drugs (including Austedo), you enter this gap. During the coverage gap, your share of the cost for brand-name drugs like Austedo increases significantly, typically to 25% of the drug's cost (with the manufacturer paying 70% and the plan paying 5%).
The amount you pay in the coverage gap counts towards your out-of-pocket maximum, helping you move towards catastrophic coverage. Being aware of when you might enter this phase and the potential cost implications for Austedo is important for financial planning.
5. Reaching Catastrophic Coverage
Once your total out-of-pocket spending on covered medications (including what you pay in the deductible, initial coverage phase, and the coverage gap) reaches a certain threshold, you exit the coverage gap and enter the "catastrophic coverage" phase. In this phase, your out-of-pocket costs for Austedo drop substantially. You would typically pay only a small copayment or coinsurance (e.g., 5% of the drug's cost) for the remainder of the calendar year.
For individuals with high-cost medications like Austedo, reaching the catastrophic coverage phase can provide significant financial relief. It's important to track your spending to anticipate when you might reach this point.
6. Exploring Financial Assistance Programs
Even with Medicare Part D coverage, the costs associated with Austedo can be substantial. Fortunately, several programs may help reduce your financial burden:
Extra Help (Low-Income Subsidy):
This Medicare program helps people with limited income and resources pay for Part D premiums, deductibles, and copayments.
Manufacturer Patient Assistance Programs:
The manufacturer of Austedo (Teva Pharmaceutical Industries Ltd.) may offer patient assistance programs to help eligible individuals afford their medication.
Non-Profit Organizations:
Various disease-specific foundations or non-profit organizations may provide financial support or resources for medication costs.
Contacting your Medicare Part D plan directly, a licensed insurance agent, a pharmacist, or a social worker can help identify potential assistance options tailored to your situation.
Summary
Navigating Medicare Part D coverage for a specialty medication like Austedo requires careful research and understanding of your specific plan's details. Factors such as formulary inclusion, drug tiers, prior authorization requirements, and the various phases of coverage—including the coverage gap and catastrophic coverage—all play a significant role in determining your out-of-pocket costs. Exploring available financial assistance programs can also be crucial in managing the expense. It is highly recommended to review your plan's Evidence of Coverage and Formulary, or contact your plan provider directly, to obtain the most accurate and personalized information regarding Austedo coverage. This information is for educational purposes only and should not be considered medical, legal, or financial advice.
